TGFB1 and breast cancer: Additionally, breast cancer cells produce immunosuppressive molecules (transforming growth factor beta (TGF-β) and interleukin- (IL-) 10) which induce tolerogenic phenotype in DCs, macrophages, and T cells [4, 5].